Huaxi biological diving fell by more than 11%
Huaxi biological plunged rapidly in the afternoon, and its share price once fell by more than 11%. At present, the turnover is nearly 1.2 billion.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
Synthetic Biology: Who Will Emerge as the Winner?
The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.
Jun 27, 2022 12:38 PM
Briefing Mar 10, 2022 09:18 PM
· Healthcare
Polish President: the issue of providing fighters to Ukraine should be jointly decided by NATO countries
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 26, 2022 12:26 PM
Briefing Mar 09, 2022 07:19 PM
Daquan energy: the polysilicon sales volume in the first quarter is expected to increase by 72.33% - 76.98% year-on-year
Briefing Dec 09, 2021 10:39 AM
Baijiu plate strength, mouth cellar line exceeds 10%
In-depth
Briefing Oct 29, 2021 11:38 AM
Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.
Briefing Sep 24, 2021 11:28 AM
· Healthcare
The medical and American plate rose sharply
See more
Read next
Insight
In-depth
Insight
In-depth
Chinese Enterprises are Ready to Tell Stories of Green China at COP28
Dec 02, 2023 12:28 AM
Insight
In-depth
Insight
In-depth